EUVIMEDDécouvrir EUVIMED
Crossref

Curcumin Alleviates Bone Cancer Pain by Inhibiting Satellite Glial Cell Activity via Janus Kinase 1/Signal Transducer and Transcription 3 Pathway Activator

Xinchao Jiang, Yi Song, Mei Fang, Xin Wang, Biao Zhang, Haiyong Li, Jianxue Qian

Phytotherapy Research · 2026-07 · 40 (7) · 4346-4366

DOI: 10.1002/ptr.70366 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-05-05. Written by Xinchao Jiang and 6 co-authors. Institution: Department of Pain Medicine, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, Suzhou, Jiangsu, People's Republic of China. Major MEDLINE topics: Curcumin, Janus Kinase 1, STAT3 Transcription Factor, Neuroglia. Cited 1 times so far (Crossref); 58 references. Funded by: Suzhou Integrated Traditional Chinese and Western Medicine Research Fund Project, Suzhou Science and Technology Plan Project, Application Form for the "Science, Education and Health Enhancement" Project of Suzhou.

RésuméSubjectsRéférences bibliographiquesCiteRelated studies

Abstract (original language)

Curcumin is the main active component of Curcuma longa L and has anti‐inflammatory, antitumor, and neuroprotective properties, making it a potential candidate for bone cancer pain management. Network pharmacology, molecular docking, and molecular dynamics simulations were used to screen and validate core therapeutic targets of curcumin in bone cancer pain. An in vivo mouse model of bone cancer pain was established via intrafemoral injection of Lewis lung cancer cells. A series of in vivo assays was conducted to evaluate pain sensitivity, bone microstructure, inflammatory cytokines, pain‐related neuropeptides, and protein expression levels. In silico analysis verified that curcumin has a strong binding affinity for JAK1 and STAT3. In vivo results demonstrated that curcumin dose‐dependently elevated the paw withdrawal threshold and latency, as well as ameliorated bone mineral density and bone destruction. Curcumin also suppressed pro‐inflammatory cytokines, substance P, calcitonin gene‐related peptides, and inhibited satellite glial cell activation by blocking the JAK1/STAT3 pathway. Notably, JAK1 agonist (RO8191) co‐administration markedly reversed the analgesic effects of curcumin. Curcumin targets the JAK1/STAT3 signaling pathway, inhibits satellite glial cell activation, downregulates pro‐inflammatory cytokine release, and pain‐related neuropeptide expression. Therefore, curcumin exerted a significant analgesic effect against bone cancer pain. Elucidating the analgesic mechanism revealed the core therapeutic targets of curcumin in treating bone cancer pain. This study provides experimental evidence for further research on bone cancer pain.

Subjects

MeSH terms (MEDLINE)

CurcuminJanus Kinase 1STAT3 Transcription FactorNeurogliaBone NeoplasmsCancer PainAnimalsSignal TransductionMiceMice, Inbred C57BLMaleMolecular Docking SimulationAnalgesicsCytokinesCell Line, Tumor

Author keywords

JAK1/STAT3 pathwaybone cancer paincurcumindorsal root ganglion inflammationsatellite glial cells

Substances

CurcuminJanus Kinase 1STAT3 Transcription FactorJak1 protein, mouseStat3 protein, mouseAnalgesicsCytokines

Authors and institutions

  • Department of Pain Medicine, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, Suzhou, Jiangsu, People's Republic of China.
  • Department of Nephrology, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, Suzhou, Jiangsu, People's Republic of China.
  • Department of Intensive Care, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, Suzhou, Jiangsu, People's Republic of China.

Funding

  • Suzhou Integrated Traditional Chinese and Western Medicine Research Fund Project
  • Suzhou Science and Technology Plan Project
  • Application Form for the "Science, Education and Health Enhancement" Project of Suzhou
  • Natural Science Foundation of Nanjing University of Chinese Medicine
  • Scientific Research Project of Jiangsu Provincial Association of Chinese Medicine

Cite

APA

Jiang, X., Song, Y., Fang, M., Wang, X., Zhang, B., Li, H., & Qian, J. (2026). Curcumin Alleviates Bone Cancer Pain by Inhibiting Satellite Glial Cell Activity via Janus Kinase 1/Signal Transducer and Transcription 3 Pathway Activator. Phytotherapy Research, 40(7), 4346-4366. https://doi.org/10.1002/ptr.70366

Vancouver

Jiang X, Song Y, Fang M, Wang X, Zhang B, Li H, et al. Curcumin Alleviates Bone Cancer Pain by Inhibiting Satellite Glial Cell Activity via Janus Kinase 1/Signal Transducer and Transcription 3 Pathway Activator. Phytotherapy Research. 2026;40(7):4346-4366. doi:10.1002/ptr.70366

BibTeX
@article{Jiang2026,
  author = {Jiang, Xinchao and Song, Yi and Fang, Mei and Wang, Xin and Zhang, Biao and Li, Haiyong and Qian, Jianxue},
  title = {Curcumin Alleviates Bone Cancer Pain by Inhibiting Satellite Glial Cell Activity via Janus Kinase 1/Signal Transducer and Transcription 3 Pathway Activator},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {7},
  pages = {4346--4366},
  doi = {10.1002/ptr.70366}
}
Start for free →